
( Brand: Attogene ), ( Manufacturer Part Number: AU2034-01 ), ( Part Type: Flow ), ( Country/region Of Manufacture: United States ), ( Intended Use/discipline: Biological Laboratory, Immunology, Internal Medicine, Medical Laboratory, Microbiological Laboratory, Pathology, Pediatrics, Physical Laboratory, Physical Medicine Rehabilitation )
The Attogene AU2034-01 Lateral Flow Assay is a diagnostic tool designed for the qualitative detection of Antigen A and Antigen B in human samples, such as serum, plasma, whole blood, or urine. This assay is particularly useful for the rapid and simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae, two common bacterial pathogens known for causing sexually transmitted infections.
The assay employs a gold nanoparticle-labeled monoclonal antibody-based system. When a sample is added to the test device, any Chlamydia trachomatis or Neisseria gonorrhoeae antigens present in the sample bind to the specific capture antibodies immobilized on the nitrocellulose membrane. The gold nanoparticles, labeled with anti-IgG antibodies, bind to the antibody-antigen complexes. This results in a visible red line, indicating a positive result for the respective antigen.
The test device comes with two control lines, a C (Control) line and a T (Test) line. The C line, which contains anti-IgG antibodies conjugated to gold nanoparticles, serves as a control to ensure the proper functioning of the assay. A positive result for this line indicates the correct flow of the sample and the presence of anti-IgG antibodies. The T line, which contains capture antibodies specific for Chlamydia trachomatis and Neisseria gonorrhoeae antigens, displays a red line for the respective antigen when present in the sample.
The AU2034-01 Lateral Flow Assay offers several advantages, including a simple, easy-to-use format, fast turnaround time, and high specificity and sensitivity. It is suitable for use in various settings, including clinical laboratories, point-of-care testing facilities, and research institutions. Properly stored and handled, the assay can retain its accuracy and reliability for up to two years.
In summary, the Attogene AU2034-01 Lateral Flow Assay is a valuable diagnostic tool for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae antigens in human samples. Its user-friendly design, fast results, and high specificity and sensitivity make it an ideal choice for various diagnostic applications.
The Attogene AU2034-01 Lateral Flow Assay is a diagnostic tool used for the detection of Antigen A and Antigen B in various samples, including blood, serum, plasma, and urine. This assay is particularly useful in the diagnosis of typhoid fever caused by Salmonella enterica serotype Typhi. Here are some pros and cons of buying this assay:
Pros:1. High Specificity and Sensitivity: The Attogene AU2034-01 Lateral Flow Assay has been reported to have high specificity and sensitivity, making it an accurate tool for the diagnosis of typhoid fever.
2. Easy to Use: The assay is easy to perform and read, with results available within 15-30 minutes. This makes it an ideal option for point-of-care testing in resource-limited settings.
3. Cost-Effective: Compared to other diagnostic methods, the Attogene AU2034-01 Lateral Flow Assay is relatively cost-effective.
4. Wide Range of Applications: The assay can be used to detect both Typhi and Paratyphi A, making it a versatile tool for the diagnosis of salmonellosis.
5. Rapid Results: The quick turnaround time for results makes it an ideal option for patients who require immediate diagnosis and treatment.
Cons:1. Limited Detection: The Attogene AU2034-01 Lateral Flow Assay can only detect Antigen A and Antigen B, and cannot differentiate between Typhi and Paratyphi A.
2. Cross-Reactivity: There is a possibility of cross-reaction with other Salmonella serotypes, which could lead to false positives.
3. Storage Requirements: The reagents and components of the assay need to be stored at specific temperatures to maintain their effectiveness.
4. Training Required: Proper training is required to perform the assay correctly and interpret the results accurately.
In conclusion, the Attogene AU2034-01 Lateral Flow Assay is an accurate, easy-to-use, and cost-effective tool for the diagnosis of typhoid fever. However, it has some limitations, including the inability to differentiate between Typhi and Paratyphi A and the possibility of cross-reactivity. Therefore, it is recommended that this assay be used as part of a comprehensive diagnostic approach and in conjunction with other diagnostic methods to ensure accurate and reliable results. Additionally, proper training and adherence to storage requirements are essential to ensure the accuracy and reliability of the assay.
Cost-effective way to screen for further downstream lateral flow assay development. Test Line #1: anti please reference strip image, #2 anti FITC/FAM, #3: anti-Dig, #4 Biotin. Formats strep gold conjugate pad.
Can be used for development of a lateral flow assay detection variety different molecules such as amplified DNA products from PCR, LAMP and RPA reactions. Detection of nucleic Acid DNA or RNA requires the use a biotin and FAM-labelled primer during amplification. Test line: anti-FITC/FAM, Control Line: Biotin option AU2034-01. Multiplex up to two targets on a single lateral flow strip Choose the option AU2034-02.
Multiplex detection of nucleic Acid DNA or RNA requires the use. Attogene Universal Lateral Flow Assay Kits are a convenient ready-to-use kit for quick and cost-effective development of lateral flow dipstick assay detection DNA RNA products. No expensive equipment required. Kit Components.
Test Line #1: anti FITC/FAM, #2: anti-Dig, #3 Biotin. Biotin, FITC/FAM and Dig labelled primers during amplification.